Latin America Smart Insulin Pen Market

研究執行與發布：Coherent Market Insights　·　發布日期 2026-06-30　·　255 頁
由量子訊息有限公司（Quantum Information）在台灣代理銷售與提供授權諮詢。

2026 年市場規模: USD 1.1 Bn
2033 年預估規模: USD 2.2 Bn
年複合成長率 CAGR: 1.8%

以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。

授權報價

Single User Price	$4,500 USD
Enterprise License	$10,000 USD

洽詢購買申請 Sample

完整報告名稱與涵蓋範圍

Latin America Smart Insulin Pen Market, By Type (First Generation, Second Generation (Bluetooth enabled pens, USB Connected pens)), By Usability (Prefilled, Reusable), By Indication (Type 1 diabetes, Type 2 diabetes), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (Latin America)

報告摘要

A smart insulin pen is an insulin delivery tool that offers some of the features of an insulin pump but without the always-connected experience required with pumps. A smart insulin pen can calculate each dose based on current blood sugar level, carbohydrate amounts, meal size, active insulin, and settings prescribed by patients doctor, deliver accurate half-unit doses, help prevent skipped or missed doses, send diabetes data to health care team whenever needed and work with patients smart phone or watch and popular diabetes data tracking platforms. Diabetes is a major public health problem that is approaching epidemic proportions globally, therefore, it is necessary to use smart insulin pens for a safe and effective administration of insulin to people suffering from Diabetes. Market Dynamics Key players operating in the market are focusing on acquisitions and partnerships, which is expected to drive the growth of the market over the forecast period. For instance, in February 2021, BIOCORP a company that designs, develops, manufactures delivery systems and innovative medical devices, entered into a partnership with Health2Sync, a Taiwan-based digital healthcare company, and SocialDiabetes, a Spain-based digital healthcare solution provider, for management of diabetes by integration of Mallya, a smart insulin pen cap manufactured by Biocorp with the digital applications developed by SocialDiabetes and Health2Sync. Furthermore, in September 2019, Sanofi S.A. and Abbott, a U.S.-based multinational medical devices and health care company, collaborated to integrate glucose sensing and insulin delivery technologies that would help to further simplify how people with diabetes manage their condition. The two companies would focus on developing FreeStyle Libre technology with insulin dosing information for future smart pens, insulin titration apps, and cloud software. Key features of the study • This report provides in-depth analysis of the Latin America smart insulin pen market and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players • It profiles key players in the Latin America smart insulin pen market based on the following parameters – Company Highlights, Types Portfolio, Key Highlights, Financial Performance, Market Strategies • Key companies covered as a part of this study include Medtronic Plc., Sanofi S.A., Novo Nordisk A/S, Eli Lilly and Company, Owen Mumford Ltd., BIOCORP, Jiangsu Delfu medical device Co., Ltd., BERLIN-CHEMIE AG, and F. Hoffmann-La Roche AG • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics • The Latin America smart insulin pen market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Latin America smart insulin pen market Market Segmentation • By Type (Revenue, USD Bn, 2021-2033) o First Generation o Second Generation  Bluetooth enabled pens  USB Connected pens • By Usability (Revenue, USD Bn, 2021-2033) o Prefilled o Reusable • By Indication (Revenue, USD Bn, 2021-2033) o Type 1 diabetes o Type 2 diabetes • By Distribution Channel (Revenue, USD Bn, 2021-2033) o Hospital Pharmacies o Retail Pharmacies o Online Pharmacies • By Region (Revenue, USD Bn, 2021-2033) o Brazil o Argentina o Mexico o Rest of Latin America • Key Players o Medtronic Plc o Sanofi S.A. o Novo Nordisk A/S o Eli Lilly and Company o Owen Mumford Ltd. o BIOCORP o Jiangsu Delfu medical device Co., Ltd. o BERLIN-CHEMIE AG o Hoffmann-La Roche AG

目錄 Table of Contents

Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Purview o Report Description  Market Definition and Scope o Executive Summary  Market Snapshot, By Type  Market Snapshot, By Usability  Market Snapshot, By Indication  Market Snapshot, By Distribution Channel  Market Snapshot, By Country o Coherent Opportunity Map (COM) 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics  Drivers  Restraints  Opportunity o Impact Analysis o PEST Analysis o Key Difference in Disposable Pen & Non-disposable Smart Insulin Pen o Technology Advancements o New Product Launch o Major Brand Analysis o Regulatory Scenario o Reimbursement Scenario o PORTER’S Analysis o Acquisition and Partnership 4. Latin America Smart Insulin Pen Market, By Type, 2021-2033, (USD Bn) o Overview  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022-2033  Segment Trends o First Generation  Overview  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Second Generation  Overview  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Bluetooth enabled pens  Overview  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o USB Connected pens  Overview  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 5. Latin America Smart Insulin Pen Market, By Usability, 2021-2033, (USD Bn) o Overview  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022-2033  Segment Trends o Prefilled  Overview  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Reusable  Overview  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 6. Latin America Smart Insulin Pen Market, By Indication, 2021-2033, (USD Bn) o Overview  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022-2033  Segment Trends o Type 1 diabetes  Overview  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Type 2 diabetes  Overview  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 7. Latin America Smart Insulin Pen Market, By Distribution Channel, 2021-2033, (USD Bn) o Overview  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2021-2033  Segment Trends o Hospital Pharmacies  Overview  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Retail Pharmacies  Overview  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Online Pharmacies  Overview  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 8. Latin America Smart Insulin Pen Market, By Country, 2021-2033, (USD Bn) o Overview  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022–2033  Regional Trends o Brazil  Overview  Market Size and Forecast, and Y-o-Y Growth, By Type, 2021-2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Usability, 2021-2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021-2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2033, (USD Bn) o Mexico  Overview  Market Size and Forecast, and Y-o-Y Growth, By Type, 2021-2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Usability, 2021-2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021-2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2033, (USD Bn) o Argentina  Overview  Market Size and Forecast, and Y-o-Y Growth, By Type, 2021-2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Usability, 2021-2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021-2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2033, (USD Bn) o Rest of Latin America  Overview  Market Size and Forecast, and Y-o-Y Growth, By Type, 2021-2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Usability, 2021-2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021-2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2033, (USD Bn) 9. Competitive Landscape o Medtronic Plc.  Company Highlights  Types Portfolio  Key Highlights  Financial Performance  Market Strategies o Sanofi S.A.  Company Highlights  Types Portfolio  Key Highlights  Financial Performance  Market Strategies o Novo Nordisk A/S  Company Highlights  Types Portfolio  Key Highlights  Financial Performance  Market Strategies o Eli Lilly and Company  Company Highlights  Types Portfolio  Key Highlights  Financial Performance  Market Strategies o Owen Mumford Ltd.  Company Highlights  Types Portfolio  Key Highlights  Financial Performance  Market Strategies o BIOCORP  Company Highlights  Types Portfolio  Key Highlights  Financial Performance  Market Strategies o Jiangsu Delfu medical device Co., Ltd.  Company Highlights  Types Portfolio  Key Highlights  Financial Performance  Market Strategies o BERLIN-CHEMIE AG  Company Highlights  Types Portfolio  Key Highlights  Financial Performance  Market Strategies o F. Hoffmann-La Roche AG  Company Highlights  Types Portfolio  Key Highlights  Financial Performance  Market Strategies o Analyst Views 10. Section o Research Methodology o About us and Services

提及公司

Medtronic PlcSanofi S.A.Novo Nordisk A/SEli Lilly and CompanyOwen Mumford Ltd.BIOCORPJiangsu Delfu medical device Co., Ltd.BERLIN-CHEMIE AGHoffmann-La Roche AG

同分類最新報告（醫療器材）

常見問題

這份報告可以先索取樣本嗎？

可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算？

報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付？如何付款？

一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。

量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・聯絡我們